China Cord Blood Corp. (CO) Hits New 1-Year Low at $4.96
China Cord Blood Corp. (NYSE:CO)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $4.96 and last traded at $4.96, with a volume of 30,109 shares changing hands. The stock had previously closed at $5.04.
A number of equities analysts recently commented on the company. Zacks Investment Research upgraded China Cord Blood Corp. from a “sell” rating to a “hold” rating in a report on Thursday, August 11th. TheStreet cut China Cord Blood Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. China Cord Blood Corp. has a consensus rating of “Hold” and an average target price of $7.00.
The stock has a market cap of $398.01 million and a P/E ratio of 26.44. The company has a 50-day moving average of $5.44 and a 200-day moving average of $5.88.
China Cord Blood Corp. (NYSE:CO) last announced its quarterly earnings results on Tuesday, June 14th. The company reported $0.03 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.03. The firm had revenue of $24.30 million for the quarter. On average, equities research analysts expect that China Cord Blood Corp. will post $0.17 EPS for the current year.
China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.